Authors: GUDEX CM HAWTHORNE MR BUTLER AG

Citation: Cm. Gudex et al., MEASURING PATIENT BENEFIT FROM BOTULINUM TOXIN IN THE TREATMENT OF DYSTONIA - FEASIBILITY OF COST-UTILITY ANALYSIS (VOL 12, PG 675, 1997), PharmacoEconomics, 13(2), 1998, pp. 230-230

Authors: GUDEX CM HAWTHORNE MR BUTLER AG DUFFEY P

Citation: Cm. Gudex et al., EFFECT OF DYSTONIA AND BOTULINUM TOXIN TREATMENT ON HEALTH-RELATED QUALITY-OF-LIFE, Movement disorders, 13(6), 1998, pp. 941-946

Authors: GUDEX CM HAWTHORNE MR BUTLER AG DUFFEY POF

Citation: Cm. Gudex et al., MEASURING PATIENT BENEFIT FROM BOTULINUM TOXIN IN THE TREATMENT OF DYSTONIA - FEASIBILITY OF COST-UTILITY ANALYSIS, PharmacoEconomics, 12(6), 1997, pp. 675-684

Authors: ABOUELHMD KA HAWTHORNE MR FLOOD LM

Citation: Ka. Abouelhmd et al., COCHLEAR IMPLANTATION IN A CASE OF WEGENERS GRANULOMATOSIS, Journal of Laryngology and Otology, 110(10), 1996, pp. 958-961